Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-27

Clinical Trial Update: The Analgesic Efficacy and Safety of Tulodesvenlafaxine in Patients With Herpes Zoster [NA]

View source ↗

Summary

Clinical trial evaluating the analgesic efficacy and safety of Tulodesvenlafaxine in patients with Herpes Zoster is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tulodesvenlafaxine (Tulodesvenlafaxine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Herpes Zoster, Pain | NA | Status: RECRUITING